ORBIMED ADVISORS LLC

Holdings History for Aerovate Therapeutics, Inc. - COM (AVTE)

Symbol: AVTE on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2024		-0.33%	$0	0	-565,374	-100%		Q2 2024
3/31/2024	0.33%	-0.11%	$16.7M	565K	-191,556	-25.3%	$29.57	Q1 2024
12/31/2023	0.34%		$17.1M	757K			$22.63	Q4 2023
9/30/2023	0.24%		$10.3M	757K			$13.57	Q3 2023
6/30/2023	0.25%		$13M	757K			$17.15	Q2 2023
3/31/2023	0.3%	0%	$15.3M	757K	-2,610	-0.34%	$20.17	Q1 2023
12/31/2022	0.46%	-0.02%	$22.3M	760K	-35,460	-4.46%	$29.30	Q4 2022
9/30/2022	0.27%	+0.11%	$13.2M	795K	+316,421	+66.1%	$16.58	Q3 2022
6/30/2022	0.15%	-0.01%	$7.48M	479K	-31,370	-6.15%	$15.63	Q2 2022
3/31/2022	0.15%	-0.01%	$9.35M	510K	-25,765	-4.81%	$18.33	Q1 2022
12/31/2021	0.08%		$6.32M	536K			$11.79	Q4 2021
9/30/2021	0.13%		$11.2M	536K			$20.98	Q3 2021
6/30/2021	0.13%	+0.13%	$12.2M	536K	+535,714	NEW	$22.83	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.